Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-BMV101 PET/CT in Idiopathic Pulmonary Fibrosis
NCT02485886Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-BMV101 in idiopathic pulmonary fibrosis (IPF), sponsored by Peking Union Medical College Hospital. Primary endpoint: Visual and semiquantitative assessment of lesions at 1 year. Status: unknown.
02
Drugs
68Ga-BMV101
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02485886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485886.